Viveve Medical (VIVE) Tops Q3 EPS by 2c

Viveve Medical (NASDAQ: VIVE) reported Q3 EPS of ($0.46), $0.02 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $1.85 million versus the consensus estimate of $1.55 million.

For earnings history and earnings-related data on Viveve Medical (VIVE) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance